The University of Chicago Header Logo

Connection

Neda Laiteerapong to Cost-Benefit Analysis

This is a "connection" page, showing publications Neda Laiteerapong has written about Cost-Benefit Analysis.
Connection Strength

0.639
  1. First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists : A Cost-Effectiveness Study. Ann Intern Med. 2022 10; 175(10):1392-1400.
    View in: PubMed
    Score: 0.181
  2. Economic Simulation Modeling in Type 2 Diabetes. Curr Diab Rep. 2020 05 17; 20(7):24.
    View in: PubMed
    Score: 0.153
  3. Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes: A Cost-Effectiveness Analysis. Ann Intern Med. 2018 02 06; 168(3):170-178.
    View in: PubMed
    Score: 0.129
  4. The public health implications of the cost-effectiveness of bariatric surgery for diabetes. Diabetes Care. 2010 Sep; 33(9):2126-8.
    View in: PubMed
    Score: 0.078
  5. Health economic analyses of the justice community opioid innovation network (JCOIN). J Subst Abuse Treat. 2021 09; 128:108262.
    View in: PubMed
    Score: 0.040
  6. Cost-effectiveness of gastric band surgery for overweight but not obese adults with type 2 diabetes in the U.S. J Diabetes Complications. 2017 Jul; 31(7):1139-1144.
    View in: PubMed
    Score: 0.031
  7. Patients who self-monitor blood glucose and their unused testing results. Am J Manag Care. 2015 Feb 01; 21(2):e119-29.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.